Loading...
Subheading 1 of 10 in heading 3002
Subheading 300215 · $5.8B of $7.9B
U.S. imports of immunological products in measured doses or for retail sale (HS 300215) totaled $5.8B in July 2026, traded with 42 countries.
Importers of Immunological Products in Measured Doses or for Retail Sale paid $86K in duties in July 2026 — an effective duty rate of 9.9% on $863K in dutiable value, based on actual customs collections rather than the published tariff schedule. Immunological Products in Measured Doses or for Retail Sale imports of $5.8B in July 2026 ran 22% above the year-to-date monthly average of $4.8B.
Last updated: July 2026 dataRetail-packaged and measured-dose immunological products — including monoclonal-antibody-based therapeutics — represent some of the highest-value pharmaceutical imports entering the US market. Germany and Ireland are the dominant suppliers, a pattern driven by the large number of FDA-approved biologics manufactured at European facilities. The US tariff schedule distinguishes monoclonal-antibody-containing products (3002150011) from other retail immunological preparations (3002150091 and 3002150100), and each line may carry different FDA review requirements at entry. Importers should verify that the foreign establishment is registered with FDA and that the specific product holds the appropriate approval or authorization before shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
2.7K shipments/mo
The HS structure separates retail/measured-dose presentations (heading 300215) from bulk non-retail forms (300214) because packaging and dosage form affect both the regulatory pathway and the commercial distribution channel. Measured-dose products are typically finished drug products subject to full FDA drug or biologics approval, while bulk forms may enter under different import authorization frameworks.
The importer must confirm the product has an active FDA Biologics License Application (BLA) or New Drug Application (NDA), that the foreign manufacturer is registered with FDA, and that the shipment is accompanied by a certificate of analysis and proper labeling. FDA may detain shipments that lack adequate documentation. Engaging a licensed customs broker with pharmaceutical experience is advisable given the complexity of admissibility review.
HSChapter 30
Supplier Network
Get discovered by U.S. importers searching for HS 300215 — Immunological Products in Measured Doses or for Retail Sale. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3002150011 | Immunological Prdcts,Contain Monoclonal Antibodies | $4.6B | 0.0011% | 0.01% | $49K |
| 3002150091 | Immunological Products for Retail Sale, NESOI | $1.2B | 0.0031% | 0.03% | $36K |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3002150100 | Immunological Products,for Retail Sale | $2.6B |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$5.8BYoY · Pro
Exports
$2.6BYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Imports · July 2026
origin
Ireland and Germany together supply 44% of it.
customs district
destination
entry
rate provision · imports
98.7% enters free of duty; the effective duty rate is 0.00%.